Reliable access to essential medicines and technology

Making lifesaving blood pressure medicines available when and where patients need them at prices they can afford.

Right: Participants in “Law & Health Security: Strengthening Nigeria’s Legal Preparedness”. Credit – Resolve to Save Lives

Reliable access to essential medicines for high blood pressure

Challenge

Blood pressure control programs can struggle to maintain a consistent, affordable supply of medicines, making it hard for patients to stick to their treatment plans and leaving them at risk for heart attack and stroke.  

Solution

We work with countries to strengthen medicine selection, forecasting, budgeting, procurement, last-mile distribution, and inventory monitoring to keep blood pressure-lowering medicines continuously available and affordable (or free) for patients.

Impact

Affordable, high-quality blood pressure-lowering medicines available in primary care clinics close to home make it easier for patients to control their blood pressure and stay healthy.

What is access to blood pressure medication?

High blood pressure can be controlled with medication—but for it to work, patients must take their medicines consistently, every day, for life. When medications are unaffordable, or are not consistently available, blood pressure control drops, often with deadly consequences.

Why are blood pressure medicines out of reach for so many?

Around the world, the cost of blood pressure medicines can be surprisingly high. Prices can vary dramatically between countries, and even within regions.

Market fragmentation, inconsistent prescribing practices, and lack of dedicated funds make it difficult to purchase enough stock or forecast future demand. As a result, prices rise and drug shortages occur, often leaving patients without the medicine they need to prevent heart attacks and strokes.

How we support medication access

We partner with countries to improve equitable access to blood pressure-lowering medicines through four complementary strategies:

1. Adopting a drug-dose specific treatment protocol

Simple treatment protocols limited to a just few safe and effective drugs and doses reduce the number of medicines that need to be managed. Their inclusion in national lists open the door for clinicians to prescribe them, states and programs to purchase them, and insurance plans to cover them.

2. Morbidity and program forecasting

We support countries to adequately forecast medicine and budget needs using a practical, adaptable tool tailored to national treatment protocols and by strengthening procurement planning and ensuring uninterrupted medicine availability as programs expand.

3. Strengthening medicine supply chains

We strengthen medicine supply chains through strategic procurement, efficient distribution, inventory monitoring, and sustainable financing approaches—including drug revolving funds where appropriate—to improve affordability and ensure uninterrupted availability of quality-assured medicines.

4. Research and evidence generation

We partner with countries and leading academic institutions to generate evidence on medicine availability, affordability, access, and unmet need. These insights inform market shaping, policy reform, and sustainable financing to improve equitable access to essential cardiovascular medicines.

Supporting access to technology

We need good data to make life-or-death decisions about blood pressure management. Inaccurate blood pressure readings can leave patients vulnerable to heart attack and stroke.

Validated automated blood pressure devices reduce human error and make it possible to manage blood pressure at the primary care level—where more people get care. RTSL partners with hypertension control programs to use these monitors widely, ensuring accurate blood pressure measurement every time.

Access to medicines in action

Resources

Screenshot 2025-12-02 at 09.34.11

Global Development Assistance for Health Allocated to Cardiovascular Disease Control, 2015 to 2022

Journal of American College of Cardiology
December 1, 2025
Cardiovascular disease (CVD) is the leading cause of death worldwide yet CVD prevention efforts remain starkly underfunded. A new landmark report in the Journal of the American College of Cardiology quantifies…
Healthy Hearts Program Philippines paper BMC Primary Care

The Healthy Hearts program to improve primary care for hypertension

BMC Primary Care
March 22, 2025
The Healthy Hearts Programme Philippines found that centralized drug procurement could reduce costs and improve hypertension care nationwide, supporting stronger and more equitable primary healthcare
Thumbnail_HEARTS Voices

Watch: “HEARTS Voices – Access to Medicines”

Resolve to Save Lives
September 4, 2025
Our new video highlights the urgent need for affordable blood pressure medicines and shows how access can save lives, urging funders, governments, and the private sector to act.
Screenshot from "One Penny, One Pill" video on cost of hypertension control

Watch: “One penny, one pill.” That’s all it costs to control high blood pressure.

Resolve to Save Lives
May 17, 2025
Governments, funders, and the private sector can improve access to blood pressure medicines for as little as one penny per pill.

Latest news